鼻咽癌
医学
放射治疗
诱导化疗
核医学
淋巴结
节的
淋巴
癌症
肿瘤科
泌尿科
内科学
病理
作者
Sezin Yüce Sarı,Ecem Yiğit,Gözde Yazıcı,İbrahim Güllü,Sercan Aksoy,Gökhan Özyiğit,Mustafa Cengiz
出处
期刊:Head & neck
[Wiley]
日期:2022-12-12
卷期号:45 (3): 612-619
被引量:2
摘要
BACKGROUND: We routinely delineate the gross tumor volume (GTV) for the lymph nodes (LN) based on post-induction chemotherapy (IC) MRI in nasopharyngeal carcinoma (NPC). Herein, we investigated the sufficiency of this method, particularly in high-risk LNs. METHODS: Eighty-one LNs with a high-risk of clinical extranodal extension and/or ≥3-cm diameter in 58 patients were evaluated. A new GTV covering the pre-IC LN volume was delineated for each LN. RESULTS: The median volume reduction was 72.5% for the GTV and 53.1% for the planning target volume. After a median 43 months, the overall LN local control rate was 97.5%. The 2- and 5-year LN recurrence-free survival, overall survival, and disease-free survival rate was 88.3% and 84.4%, 92.5% and 85.1%, and 86.8% and 79.2%, respectively. CONCLUSION: IC yields a significant reduction in nodal target volumes, and post-IC nodal volume-based radiotherapy provides excellent LC in NPC, even in high-risk LNs.
科研通智能强力驱动
Strongly Powered by AbleSci AI